STAT – Vice President Joe Biden says he plans to dedicate his career after politics to cancer research — and to do so for “as long as I’m alive” — but ruled out serving in Hillary Clinton’s administration should she win the White House this fall.
The Verge – The decision to sell the DNA to Tiziana angered many local residents, who argued that they had agreed to donate DNA as a form of public service and did not approve of their genetic material being sold to a for-profit business.
Science Magazine – A rare policy window recently opened: an explosion of genetic engineering (GE) techniques and products challenging federal oversight; intensifying public, media, and political attention; and a growing number of policy ideas for change.
PharmaLive – Orphan designation qualifies drug companies for development incentives that include financial grants, increased access to regulatory agencies, protocol assistance, extended periods of market exclusivity, and fee reductions and waivers.
Science Magazine – A new report on how the next U.S. president should manage the nation’s science portfolio comes with an invisible sticker on its cover: Open and read immediately if Donald Trump is elected.